Ulrika Lorentzon Fagerberg

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Institutionen för Kvinnors och Barns Hälsa, Klinisk pediatrik, Karolinska
Institutet, Stockholm
Överläkare och Senior forskare inom Pediatrisk Gastroenterologi, Hepatologi
och Nutrition.
Arbetsplats: Barnkliniken/Centrum för Innovation, Forskning och Utbildning
(CIFU), Västmanland sjukhus, Västerås, Ingång 29, SE-72189 Västerås,
telefon +4621173000.

Forskningsbeskrivning

Klinisk forskning om magtarm-sjukdomar med fokus på kronisk inflammatorisk
tarmsjukdom (IBD) hos barn och vuxna.

Artiklar

Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2024;12(8):2127-2134.e1
Resolution of Food Protein-Induced Enterocolitis Syndrome-A Long-Term Follow-Up Study of 113 Swedish Children.
Ullberg J; Ullberg D; Fech-Bormann M; Fagerberg UL
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(4):831-846
Histologic Activity in Inflammatory Bowel Disease and Risk of Serious Infections: A Nationwide Study
Marild K; Soderling J; Axelrad J; Halfvarson J; Forss A; Olen O; Ludvigsson JF
Article: EUROPEAN JOURNAL OF PAIN. 2022;26(2):336-348
Dance and yoga reduced functional abdominal pain in young girls: A randomized controlled trial
Hogstrom S; Philipson A; Ekstav L; Eriksson M; Fagerberg UL; Falk E; Moller M; Sandberg E; Sarnblad S; Duberg A
Article: CLINICAL EPIDEMIOLOGY. 2022;14:591-600
Identification of Childhood-Onset Inflammatory Bowel Disease in Swedish Healthcare Registers: A Validation Study
Mouratidou N; Malmborg P; Jaras J; Sigurdsson V; Sandstrom O; Fagerberg UL; Broms G; Ludvigsson JF; Olen O
Article: FRONTIERS IN PEDIATRICS. 2022;10:836406
Saliva Cortisol in Girls With Functional Abdominal Pain Disorders: A Randomized Controlled Dance and Yoga Intervention
Areskoug Sandberg E; Duberg A; Lorenzon Fagerberg U; Moerelius E; Saernblad S
Article: ALLERGY. 2021;76(7):2115-2122
Clinical presentation and management of food protein-induced enterocolitis syndrome in 113 Swedish children
Ullberg J; Fech-Bormann M; Fagerberg UL
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2021;53(4):471-483
Drug survival of anti-TNF agents compared with vedolizumab as a second-line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers
Rundquist S; Sachs MC; Eriksson C; Olen O; Montgomery S; Halfvarson J
Article: JMIR RESEARCH PROTOCOLS. 2020;9(12):e19748
An Intervention With Dance and Yoga for Girls With Functional Abdominal Pain Disorders (Just in TIME): Protocol for a Randomized Controlled Trial
Philipson A; Sarnblad S; Ekstav L; Eriksson M; Fagerberg UL; Moller M; Morelius E; Duberg A
Article: JOURNAL OF CROHNS & COLITIS. 2020;15(2):jjaa161-194
The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update
van Rheenen PF; Aloi M; Assa A; Bronsky J; Escher JC; Fagerberg UL; Gasparetto M; Gerasimidis K; Griffiths A; Henderson P; Koletzko S; Kolho K-L; Levine A; van Limbergen J; de Carpi FJM; Navas-Lopez VM; Oliva S; de Ridder L; Russell RK; Shouval D; Spinelli A; Turner D; Wilson D; Wine E; Ruemmele FM
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2020;52(4):655-668
Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden
Khalili H; Everhov AH; Halfvarson J; Ludvigsson JF; Askling J; Myrelid P; Soderling J; Olen O; Neovius M
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(4):430-435
The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register
Shrestha S; Olen O; Eriksson C; Everhov AH; Myrelid P; Visuri I; Ludvigsson JF; Schoultz I; Montgomery S; Sachs MC; Halfvarson J; Olsson M; Hjortswang H; Bengtsson J; Strid H; Andersson M; Jaghult S; Eberhardson M; Nordenvall C; Bjork J; Fagerberg UL; Rejler M; Grip O; Karling P; Block M; Angenete E; Hellstrom PM; Gustaysson A
Article: ACTA PAEDIATRICA. 2019;108(6):1140-1143
Questionnaire showed that Swedish paediatric clinics complied well with the revised European guidelines for diagnosing coeliac disease
Myleus A; Stenhammar L; Hogberg L; Browaldh L; Daniels I-M; Fagerberg UL; Gudjonsdottir AH; Malmquist M; Sandstrom O; Ivarsson A
Article: NUTRIENTS. 2019;11(2):E414-414
Exclusive Enteral Nutrition: Clinical Effects and Changes in Mucosal Cytokine Profile in Pediatric New Inflammatory Bowel Disease
Rolandsdotter H; Jonsson-Videsater K; Fagerberg UL; Finkel Y; Eberhardson M
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2018;48(5):523-537
Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN
Joosse ME; Aardoom MA; Kemos P; Turner D; Wilson DC; Koletzko S; Martin-de-Carpi J; Fagerberg UL; Spray C; Tzivinikos C; Sladek M; Shaoul R; Roma-Giannikou E; Bronsky J; Serban DE; Ruemmele FM; Garnier-Lengline H; Veres G; Hojsak I; Kolho KL; Davies IH; Aloi M; Lionetti P; Hussey S; Veereman G; Braegger CP; Trindade E; Wewer AV; Hauer AC; de Vries ACH; Boneh RS; Shabat CS; Levine A; de Ridder L
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2018;66(4):e103-e107
Mucosal Cytokine Profiles After Induction Therapy With Granulocyte/Monocyte Apheresis in New-onset Inflammatory Colitis
Rolandsdotter H; Jonsson-Videsater K; Fagerberg UL; Eberhardson M; Finkel Y
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2018;66(1):84-89
Granulocyte and Monocyte Apheresis for Induction of Remission in Children With New-Onset Inflammatory Bowel Colitis
Rolandsdotter H; Eberhardson M; Fagerberg UL; Finkel Y
Article: JAMA PEDIATRICS. 2017;171(10):984-991
Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children A Meta-analysis of Individual Patient Data
Holtman GA; Lisman-van Leeuwen Y; Day AS; Fagerberg UL; Henderson P; Leach ST; Perminow G; Mack D; van Rheenen PF; de Vijver EV; Wilson DC; Reitsma JB; Berger MY
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2017;18(3):E575-575
Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on Maintenance Treatment
Rolandsdotter H; Marits P; Sundin U; Wikstrom A-C; Fagerberg UL; Finkel Y; Eberhardson M
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2017;45(4):519-532
Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients
Angelison L; Almer S; Eriksson A; Karling P; Fagerberg U; Halfvarson J; Thorn M; Bjork J; Hindorf U; Lofberg R; Bajor A; Hjortswang H; Hammarlund P; Grip O; Torp J; Marsal J; Hertervig E
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2015;60(3):339-346
Faecal Calprotectin in Suspected Paediatric Inflammatory Bowel Disease
Degraeuwe PLJ; Beld MPA; Ashorn M; Canani RB; Day AS; Diamanti A; Fagerberg UL; Henderson P; Kolho K-L; Van de Vijver E; van Rheenen PF; Wilson DC; Kessels AGH
Article: JOURNAL OF CROHNS & COLITIS. 2014;8(10):1179-1207
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
Ruemmele FM; Veres G; Kolho KL; Griffiths A; Levine A; Escher JC; Dias JA; Barabino A; Braegger CP; Bronsky J; Buderus S; Martin-de-Carpi J; De Ridder L; Fagerberg UL; Hugot JP; Kierkus J; Kolacek S; Koletzkou S; Lionetti P; Miele E; Navas Lopez VM; Paerregaard A; Russell RK; Serban DE; Shaoul R; Van Rheenen P; Veereman G; Weiss B; Wilson D; Dignass A; Eliakim A; Winter H; Turner D
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2014;49(8):950-957
Pediatric Crohn's disease from onset to adulthood: granulomas are associated with an early need for immunomodulation
Idestrom M; Rubio CA; Onelov E; Henter J-I; Fagerberg UL; Finkel Y
Article: INFLAMMATORY BOWEL DISEASES. 2014;20(2):291-300
Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group
de Ridder L; Turner D; Wilson DC; Koletzko S; Martin-de-Carpi J; Fagerberg UL; Spray C; Sladek M; Shaoul R; Roma-Giannikou E; Bronsky J; Serban DE; Cucchiara S; Veres G; Ruemmele FM; Hojsak I; Kolho KL; Davies IH; Aloi M; Lionetti P; Veereman-Wauters G; Braegger CP; Trindade E; Wewer AV; Hauer A; Levine A
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2012;55(3):340-361
Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-based Consensus Guidelines
Turner D; Levine A; Escher JC; Griffiths AM; Russell RK; Dignass A; Dias JA; Bronsky J; Braegger CP; Cucchiara S; de Ridder L; Fagerberg UL; Hussey S; Hugot J-P; Kolacek S; Kolho KL; Lionetti P; Pcerregaard A; Potapov A; Rintala R; Serban DE; Staiano A; Sweeny B; Veerman G; Veres G; Wilson DC; Ruemmele FM
Article: INFLAMMATORY BOWEL DISEASES. 2012;18(3):520-528
Manifestations of small bowel disease in pediatric Crohn's disease on magnetic resonance enterography
Torkzad MR; Ullberg U; Nystrom N; Blomqvist L; Hellstrom P; Fagerberg UL
Article: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 2009;21(10):1168-1176
Infliximab in clinical routine: experience with Crohn's disease and biomarkers of inflammation over 5 years
Lonnkvist MH; Befrits R; Lundberg JO; Lundahl J; Fagerberg UL; Hjortswang H; van Hage M; Hellstrom PM
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2007;45(4):414-420
Fecal calprotectin:: A quantitative marker of colonic inflammation in children with inflammatory bowel disease
Fagerberg UL; Loof L; Lindholm J; Hansson L-O; Finkel Y
Article: ACTA PAEDIATRICA. 2007;96(7):1076-1079
No evidence for a clear link between active intestinal inflammation and autism based on analyses of faecal calprotectin and rectal nitric oxide
Fernell E; Fagerberg UL; Hellstrom PM
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2006;24(2):331-342
Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease
Hindorf U; Lindqvist M; Hildebrand H; Fagerberg U; Almer S
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2005;40(4):450-455
Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms
Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2003;37(4):468-472
Fecal calprotectin levels in healthy children studied with an improved assay
Fagerberg UL; Lööf L; Merzoug RD; Hansson LO; Finkel Y
Visa fler

Alla övriga publikationer

Review: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2019;54(9):1089-1101
Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality register
Ludvigsson JF; Andersson M; Bengtsson J; Eberhardson M; Fagerberg UL; Grip O; Halfvarson J; Hjortswang H; Jaghult S; Karling P; Nordenvall C; Olen O; Olsson M; Rejler M; Strid H; Myrelid P
Thesis / dissertation: 2007
Fecal calprotectin in children with special reference to inflammatory bowel disease
Fagerberg, Ulrika Lorentzon

Anställningar

Anknuten till Forskning, Kvinnors och barns hälsa, Karolinska Institutet, 2024-2027

Examina och utbildning

MEDICINE DOKTORSEXAMEN, Institutionen för kvinnors och barns hälsa, Karolinska Institutet, 2007

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI